Literature DB >> 10386933

Potential anxiolytic agents. 3. Novel A-ring modified pyrido[1,2-a]benzimidazoles.

B E Maryanoff1, S O Nortey, J J McNally, P J Sanfilippo, D F McComsey, B Dubinsky, R P Shank, A B Reitz.   

Abstract

A variety of pyrido[1,2-a]benzimidazoles (PBIs) modified on the A-ring were prepared and evaluated for affinity to the benzodiazepine binding site on the GABA-A receptor and in animal models predictive of anxiolytic activity in humans. A-ring benzo-fused derivative 7 exhibited potent activity, as did the 6- and 7-pyrido compounds 3 and 4.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10386933     DOI: 10.1016/s0960-894x(99)00240-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Metabolism of the new nonbenzodiazepine anxiolytic agent, RWJ-51204, in mouse, rat, dog, monkey and human hepatic S9 fractions, and in rats, dogs and humans.

Authors:  W N Wu; L A McKown; A B Reitz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Oct-Dec       Impact factor: 2.441

2.  Human hepatic metabolism of the anxiolytic agent, RWJ-51521--API-MS/MS identification of metabolites.

Authors:  W N Wu; L A McKown; A B Reitz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Oct-Dec       Impact factor: 2.441

3.  Antioxidative and antiproliferative activities of novel pyrido[1,2-a]benzimidazoles.

Authors:  Martina Tireli; Kristina Starčević; Tamara Martinović; Sandra Kraljević Pavelić; Grace Karminski-Zamola; Marijana Hranjec
Journal:  Mol Divers       Date:  2016-09-27       Impact factor: 2.943

4.  Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.

Authors:  Wu-Nan Wu; Linda A McKown; Allen B Reitz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Oct-Dec       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.